Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 15, 2015 - Issue 10
Submit an article Journal homepage
671
Views
31
CrossRef citations to date
0
Altmetric
Original Research

Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study

Ali A RizviUniversity of South Carolina School of Medicine, Division of Endocrinology, Diabetes and Metabolism, Columbia, SC, USA
,
Angelo Maria PattiUniversity of Palermo, Biomedical Department of Internal Medicine and Medical Specialties, Via del Vespro, 141, 90127, Palermo, Italy+39 091 6552945; +39 091 6552945; [email protected]
,
Rosaria Vincenza GiglioUniversity of Palermo, Biomedical Department of Internal Medicine and Medical Specialties, Via del Vespro, 141, 90127, Palermo, Italy+39 091 6552945; +39 091 6552945; [email protected]
,
Dragana NikolicUniversity of Palermo, Biomedical Department of Internal Medicine and Medical Specialties, Via del Vespro, 141, 90127, Palermo, Italy+39 091 6552945; +39 091 6552945; [email protected]
,
Antonella AmatoUniversity of Palermo, Department of Biological, Chemical and Pharmaceutical Sciences and Technologies, Palermo, Italy
,
Noor Al-BusaidiSultan Qaboos University Hospital, Department of Clinical Biochemistry, Muscat, Oman
,
Khalid Al-RasadiSultan Qaboos University Hospital, Department of Clinical Biochemistry, Muscat, Oman
,
Maurizio SoresiUniversity of Palermo, Biomedical Department of Internal Medicine and Medical Specialties, Via del Vespro, 141, 90127, Palermo, Italy+39 091 6552945; +39 091 6552945; [email protected]
,
Maciej BanachUniversity of Lodz, Department of Hypertension, Chair of Nephrology and Hypertension, Lodz, Poland
,
Giuseppe MontaltoUniversity of Palermo, Biomedical Department of Internal Medicine and Medical Specialties, Via del Vespro, 141, 90127, Palermo, Italy+39 091 6552945; +39 091 6552945; [email protected]
&
Manfredi RizzoUniversity of South Carolina School of Medicine, Division of Endocrinology, Diabetes and Metabolism, Columbia, SC, USA;University of Palermo, Biomedical Department of Internal Medicine and Medical Specialties, Via del Vespro, 141, 90127, Palermo, Italy+39 091 6552945; +39 091 6552945; [email protected]
, MD PhD show all
Pages 1391-1397 | Published online: 20 Jul 2015

Citations (31)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Manfredi Rizzo, Francesco Cosentino & Christos Mantzoros. (2022) Biosimilar and generic formulations of novel antidiabetic drugs: the role of liraglutide in clinical pharmacology of type 2 diabetes. Expert Review of Clinical Pharmacology 15:7, pages 795-797.
Read now
Angelo Maria Patti, Rosaria Vincenza Giglio, Nikolaos Papanas, Manfredi Rizzo & Ali A. Rizvi. (2019) Future perspectives of the pharmacological management of diabetic dyslipidemia. Expert Review of Clinical Pharmacology 12:2, pages 129-143.
Read now

Articles from other publishers (29)

Yajnavalka Banerjee, Angelo M. Patti, Rosaria V. Giglio, Marcello Ciaccio, Suhina Vichithran, Shemima Faisal, Anca Panta Stoian, Ali Abbas Rizvi & Manfredi Rizzo. (2023) The role of atherogenic lipoproteins in diabetes: Molecular aspects and clinical significance. Journal of Diabetes and its Complications 37:8, pages 108517.
Crossref
Aris Bechlioulis, Georgios Markozannes, Ifigeneia Chionidi, Evangelos Liberopoulos, Katerina K. Naka, Evangelia E. Ntzani, Stavros Liatis, Manfredi Rizzo & Evangelos C. Rizos. (2023) The effect of SGLT2 inhibitors, GLP1 agonists, and their sequential combination on cardiometabolic parameters: A randomized, prospective, intervention study. Journal of Diabetes and its Complications 37:4, pages 108436.
Crossref
Daqing Zhang, Zhen Mi, Jiya Peng, Tiangui Yang, Yuze Han, Yujia Zhai, Chenliang Song, Xianzhuo Teng, Wei Sun, Jing Guo & Kabeya Paulin Bilonda. (2023) Nonalcoholic Fatty Liver Disease as an Emerging Risk Factor and Potential Intervention Target for Atherosclerotic Cardiovascular Diseases. Journal of Cardiovascular Pharmacology 81:5, pages 327-335.
Crossref
Emir Muzurović, Manfredi Rizzo & Dimitri P. Mikhailidis. (2022) Obesity and nonalcoholic fatty liver disease in type 1 diabetes mellitus patients. Journal of Diabetes and its Complications 36:12, pages 108359.
Crossref
Zaynab Ahmad Mouhammad, Rupali Vohra, Anna Horwitz, Anna-Sophie Thein, Jens Rovelt, Barbara Cvenkel, Pete A. Williams, Augusto Azuara-Blanco & Miriam Kolko. (2022) Glucagon-Like Peptide 1 Receptor Agonists – Potential Game Changers in the Treatment of Glaucoma?. Frontiers in Neuroscience 16.
Crossref
Wei Peng, Rui Zhou, Ze-Fang Sun, Jia-Wei Long & Yong-Qiang Gong. (2022) Novel Insights into the Roles and Mechanisms of GLP-1 Receptor Agonists against Aging-Related Diseases. Aging and disease 13:2, pages 468.
Crossref
Emir M. Muzurović, Špela Volčanšek, Karin Zibar Tomšić, Andrej Janež, Dimitri P. Mikhailidis, Manfredi Rizzo & Christos S. Mantzoros. (2022) Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease—Current Evidence. Journal of Cardiovascular Pharmacology and Therapeutics 27, pages 107424842211463.
Crossref
Karolina Drożdż, Katarzyna Nabrdalik, Weronika Hajzler, Hanna Kwiendacz, Janusz Gumprecht & Gregory Y. H. Lip. (2021) Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota. Nutrients 14:1, pages 103.
Crossref
Mohamad Khalil, Soukayna Hayek, Nour Khalil, Nadia Serale, Laura Vergani, Maria Calasso, Maria De Angelis & Piero Portincasa. (2021) Role of Sumac (Rhus coriaria L.) in the management of metabolic syndrome and related disorders: Focus on NAFLD-atherosclerosis interplay. Journal of Functional Foods 87, pages 104811.
Crossref
Amanda J. Berberich & Robert A. Hegele. (2021) Lipid effects of glucagon-like peptide 1 receptor analogs. Current Opinion in Lipidology 32:3, pages 191-199.
Crossref
Angelo M. Patti, Giuseppe Carruba, Arrigo F. G. Cicero, Maciej Banach, Dragana Nikolic, Rosaria V. Giglio, Antonino Terranova, Maurizio Soresi, Lydia Giannitrapani, Giuseppe Montalto, Anca Pantea Stoian, Yajnavalka Banerjee, Ali A. Rizvi, Peter P. Toth & Manfredi Rizzo. (2020) Daily Use of Extra Virgin Olive Oil with High Oleocanthal Concentration Reduced Body Weight, Waist Circumference, Alanine Transaminase, Inflammatory Cytokines and Hepatic Steatosis in Subjects with the Metabolic Syndrome: A 2-Month Intervention Study. Metabolites 10:10, pages 392.
Crossref
Alexandros Sachinidis, Dragana Nikolic, Anca Pantea Stoian, Nikolaos Papanas, Omer Tarar, Ali A. Rizvi & Manfredi Rizzo. (2020) Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors. Metabolism 111, pages 154343.
Crossref
Rosaria Vincenza Giglio, Dragana Nikolic, Giovanni Li Volti, Anca Pantea Stoian, Yajnavalka Banerjee, Antonio Magan-Fernandez, Giuseppa Castellino, Angelo Maria Patti, Roberta Chianetta, Carlo Castruccio Castracani, Giuseppe Montalto, Ali A. Rizvi, Giorgio Sesti & Manfredi Rizzo. (2020) Liraglutide Increases Serum Levels of MicroRNA-27b, -130a and -210 in Patients with Type 2 Diabetes Mellitus: A Novel Epigenetic Effect. Metabolites 10:10, pages 391.
Crossref
Anna Maria Rychter, Marzena Skrzypczak-Zielińska, Aleksandra Zielińska, Piotr Eder, Eliana B. Souto, Agnieszka Zawada, Alicja Ewa Ratajczak, Agnieszka Dobrowolska & Iwona Krela-Kaźmierczak. (2020) Is the Retinol-Binding Protein 4 a Possible Risk Factor for Cardiovascular Diseases in Obesity?. International Journal of Molecular Sciences 21:15, pages 5229.
Crossref
Angelo Maria Patti, Ali A Rizvi, Rosaria Vincenza Giglio, Anca Pantea Stoian, Daniela Ligi & Ferdinando Mannello. (2020) Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes. Journal of Clinical Medicine 9:4, pages 912.
Crossref
Shabnam Radbakhsh, Thozhukat Sathyapalan, Maciej Banach & Amirhossein Sahebkar. (2020) Incretins and microRNAs: Interactions and physiological relevance. Pharmacological Research 153, pages 104662.
Crossref
Vasilios G. Athyros, Stergios A. Polyzos, Jiannis Kountouras, Niki Katsiki, Panagiotis Anagnostis, Michael Doumas & Christos S. Mantzoros. (2020) Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block. Current Vascular Pharmacology 18:2, pages 172-181.
Crossref
Hesham Alharby, Talaat Abdelati, Mostafa Rizk, Eman Youssef, Noha Gaber, Khaled Moghazy & Saeed Yafei. (2019) Association of fasting glucagon-like peptide-1 with oxidative stress and subclinical atherosclerosis in type 2 diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 13:2, pages 1077-1080.
Crossref
Angelo Maria Patti, Dragana Nikolic, Antonio Magan-Fernandez, Rosaria Vincenza Giglio, Giuseppa Castellino, Roberta Chianetta, Roberto Citarrella, Egle Corrado, Francesca Provenzano, Vincenzo Provenzano, Giuseppe Montalto, Ali A. Rizvi & Manfredi Rizzo. (2019) Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study. Diabetes Research and Clinical Practice 149, pages 163-169.
Crossref
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrera, L. Cisneros-Garza, J. Flores-Calderón, D. García-Compeán, Y. Gutiérrez-Grobe, M.F. Higuera de la Tijera, D. Kershenobich-Stalnikowitz, L. Ladrón de Guevara-Cetina, J. Lizardi-Cervera, J.A. López-Cossio, S. Martínez-Vázquez, E. Márquez-Guillén, N. Méndez-Sánchez, R. Moreno-Alcantar, J.L. Poo-Ramírez, P. Ramos-Martínez, H. Rodríguez-Hernández, J.F. Sánchez-Ávila, M. Stoopen-Rometti, A. Torre-Delgadillo, G. Torres-Villalobos, R. Trejo-Estrada, M. Uribe-Esquivel & J.A. Velarde-Ruiz Velasco. (2019) The Mexican consensus on nonalcoholic fatty liver disease. Revista de Gastroenterología de México (English Edition) 84:1, pages 69-99.
Crossref
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrera, L. Cisneros-Garza, J. Flores-Calderón, D. García-Compeán, Y. Gutiérrez-Grobe, M.F. Higuera de la Tijera, D. Kershenobich-Stalnikowitz, L. Ladrón de Guevara-Cetina, J. Lizardi-Cervera, J.A. López-Cossio, S. Martínez-Vázquez, E. Márquez-Guillén, N. Méndez-Sánchez, R. Moreno-Alcantar, J.L. Poo-Ramírez, P. Ramos-Martínez, H. Rodríguez-Hernández, J.F. Sánchez-Ávila, M. Stoopen-Rometti, A. Torre-Delgadillo, G. Torres-Villalobos, R. Trejo-Estrada, M. Uribe-Esquivel & J.A. Velarde-Ruiz Velasco. (2019) Consenso mexicano de la enfermedad por hígado graso no alcohólico. Revista de Gastroenterología de México 84:1, pages 69-99.
Crossref
Malak Almutairi, Rami Al Batran & John R. Ussher. (2019) Glucagon-like peptide-1 receptor action in the vasculature. Peptides 111, pages 26-32.
Crossref
Feng Tian, Zhigang Zheng, Damin Zhang, Si He & Jie Shen. (2018) Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease. Bioscience Reports 38:6.
Crossref
Su-Kyung Shin, Hyun-Woo Cho, Seung-Eun Song & Dae-Kyu Song. (2018) Catalase and nonalcoholic fatty liver disease. Pflügers Archiv - European Journal of Physiology 470:12, pages 1721-1737.
Crossref
Manfredi Rizzo, Dragana Nikolic, Angelo Maria Patti, Carlo Mannina, Giuseppe Montalto, Brooke S. McAdams, Ali A. Rizvi & Francesco Cosentino. (2018) GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1864:9, pages 2814-2821.
Crossref
Yun Kyung Cho, Yu Mi Kang, Jee Hee Yoo, Jiwoo Lee, Seung Eun Lee, Dong Hyun Yang, Joon-Won Kang, Joong-Yeol Park, Chang Hee Jung, Hong-Kyu Kim & Woo Je Lee. (2018) The impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcification. Scientific Reports 8:1.
Crossref
Kalliopi Pafili, Manfredi Rizzo & Nikolaos Papanas. (2018) New antihyperglycaemic agents and cardiovascular disease. Current Opinion in Cardiology 33:4, pages 444-454.
Crossref
Laura Iogna Prat & Emmanuel A. Tsochatzis. (2018) The effect of antidiabetic medications on non-alcoholic fatty liver disease (NAFLD). Hormones 17:2, pages 219-229.
Crossref
Gloria Torres, Pablo E. Morales, Marina Garc?a-Miguel, Ignacio Norambuena-Soto, Benjam?n Cartes-Saavedra, Gonzalo Vidal-Pe?a, David Moncada-Ruff, Fernanda Sanhueza-Olivares, Alejandra San Mart?n & Mario Chiong. (2016) Glucagon-like peptide-1 inhibits vascular smooth muscle cell dedifferentiation through mitochondrial dynamics regulation. Biochemical Pharmacology 104, pages 52-61.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.